PyrAmes, Inc.
PrivateLast Round
Series B
Nov 9, 2026
Total Funding Raised
$6.03M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
PyrAmes, Inc. operates in Healthcare & Life Sciences and is based in Cupertino, California. Its latest recorded funding round was a Series B round in November 2026.
PyrAmes, Inc. is a digital health company that develops a proprietary platform for continuous, accurate, wireless, and non-invasive blood pressure monitoring for patients ranging from newborns to seniors.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PyrAmes, Inc. Comparables
Compare PyrAmes, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Caretaker Medical | 84% | |
| Biobeat | 84% | |
| Sibel Health | 81% |
For institutional investors. Book with your work email.
PyrAmes, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 9, 2026 | ||||
| Grant | Aug 21, 2023 | ||||
| Strategic | May 1, 2023 | ||||
| Grant | Oct 21, 2022 | ||||
| Series A | Apr 20, 2021 | ||||
Grant | Apr 15, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PyrAmes, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| GSR Ventures | Series A |
| SWPDC | Grant |
| The Consortium for Technology & Innovation in Pediatrics | Grant |
| Keytone Ventures | Series A |
| XTX Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2026
Completed a Series B funding round.
- Mar 2, 2026
Monthly visitors grew 91% MoM, reaching 2.2K.
For institutional investors. Book with your work email.
PyrAmes, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PyrAmes, Inc.'s valuation, stock price, and market status.
Is PyrAmes, Inc. a public or private company?
PyrAmes, Inc. is a private company.
What is the current stock price of PyrAmes, Inc.?
PyrAmes, Inc. is a private company, so its shares have no public market price. Caplight tracks PyrAmes, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PyrAmes, Inc. worth (valuation)?
Valuation information for PyrAmes, Inc. is not publicly available.
Can I buy PyrAmes, Inc. stock?
PyrAmes, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PyrAmes, Inc.'s last funding round?
PyrAmes, Inc.'s most recent funding round was Series B on November 9, 2026.
Who are the main investors in PyrAmes, Inc.?
Key investors in PyrAmes, Inc. include GSR Ventures.
Will PyrAmes, Inc. IPO soon?
No public IPO plans have been announced for PyrAmes, Inc..
How can I track PyrAmes, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in PyrAmes, Inc.'s shares on secondary markets.